Health1 day ago
Anavex Shares Plunge 47% Following EU Rejection of Alzheimer’s Therapy
Anavex Life Sciences experienced a significant decline in its stock value, dropping approximately 47% in premarket trading on Friday, March 15, 2024. This sharp fall follows...